Journals / Turkish Journal of Biology / 2019 / Cilt: 43 - Sayı: 3

Effects of B2O3 (boron trioxide) on colon cancer cells: our first-step experience and in vitro results

Pages
209–223
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The prepared boron oxide compounds may hold the potential to be applied locally to theremaining tissue after surgery and further research and evaluation will be needed to determine its effectiveness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Boron oxide (B2O3) is derived from dehydration of boric acid and is a colorless, semitransparent, crystalline compound thatis moderately soluble in water.
📊
Key Findings & Data:For all these reasons we aimed to evaluate the in vitro test results of B2O3 in termsof cytotoxicity, genotoxicity, apoptosis, and necrotic effects on L929 fibroblast cells and DLD-1 colorectal adenocarcinoma cells.
💡
Conclusion & Impact:The prepared boron oxide compounds may hold the potential to be applied locally to theremaining tissue after surgery and further research and evaluation will be needed to determine its effectiveness.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Boron oxide (B2O3) is derived from dehydration of boric acid and is a colorless, semitransparent, crystalline compound thatis moderately soluble in water. On the other hand, boron oxide is chemically hygroscopic. This gives the molecule the ability to soakup water and adhere to tissues. Boron oxide can be used locally after tumor debulking in inoperable tumors and especially when thetumor-free margin distance cannot be provided. For all these reasons we aimed to evaluate the in vitro test results of B2O3 in termsof cytotoxicity, genotoxicity, apoptosis, and necrotic effects on L929 fibroblast cells and DLD-1 colorectal adenocarcinoma cells. Ourstudies demonstrated that boron oxide compounds appear to be highly cytotoxic for both cell lines according to WST cell viability assay(44.22% and 18.36% on DLD-1 and L929, respectively). Although no genotoxic effects were observed, boron oxide compounds showedantiproliferative effects for both cell lines. The prepared boron oxide compounds may hold the potential to be applied locally to theremaining tissue after surgery and further research and evaluation will be needed to determine its effectiveness.

🔖

Cite This Article

DÜLGER, D., TÜRK, M., YALÇINª, S., AYDIN, F., ALBUZ, Ö., TUNALI, B. Ç. (2022). Effects of B2O3 (boron trioxide) on colon cancer cells: our first-step experience and in vitro results. Turkish Journal of Biology, Cilt: 43 - Sayı: 3, 209–223. https://ajindex.com/articles/600197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR et al. (1998). Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorganic & Medicinal Chemistry Letters 8: 333-338.
  2. AICR (2018). Colorectal Cancer Statistics. Arlington, VA, USA: American Institute for Cancer Research. Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V et al. (2009). Therapeutic potential of boron-containing compounds. Future Medicinal Chemistry 1: 1275-1288.
  3. Bergsbaken T, Fink SL, Cookson BT (2009). Pyroptosis: host cell death and inflammation. Nature Reviews Microbiology 7: 99. Chattopadhyay N, Berger AJ, Koenig E, Bannerman B, Garnsey J et al. (2015). KRAS genotype correlates with proteasome inhibitor ixazomib activity in preclinical in vivo models of colon and non-small cell lung cancer: potential role of tumor metabolism. PLoS one 10: e0144825. Cunningham CC (2007). Talabostat. Expert Opinion on Investigational Drugs 16: 1459-1465.
  4. Demir C (2007). Bor minerallerinin enerji kaynağı olarak değerlendirilmesi. MSc, Selçuk University, Konya, Turkey (in Turkish) Dobrydneva Y, Blackmore P (2001). 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Molecular Pharmacology 60: 541-552.
  5. Ediz N, Özdağ H (2001). Bor mineralleri ve ekonomisi. Dumlupınar Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2001: 133-151 (in Turkish). EFSA (2013). Scientific opinion on the re‐evaluation of boric acid (E 284) and sodium tetraborate (borax) (E 285) as food additives. EFSA Journal 11: 3407. Engür S, Dikmen M (2017). The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib. Acta Clinica Belgica 72: 391-398.
  6. Feng M, Feng J, Chen W, Wang W, Wu X et al. (2016). Lipocalin 2 suppresses metastasis of colorectal cancer by attenuating NFκB-dependent activation of snail and epithelial mesenchymal transition. Molecular Cancer 15: 77. Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 2008: pdb.prot4986. Geniş B, Coşar B (2018). Mania associated with the use of bortezomib and dexamethasone. Turk Psikiyatri Dergisi 29: 209-215 (in Turkish with abstract in English). Gilbert B, Perfetti L, Fauchoux O, Redondo J, Baudat PA et al. (2000). Spectromicroscopy of boron in human glioblastomas following administration of Na2 B12H11SH. Physical Review E 62: 1110. Glynn SJ, Gaffney KJ, Sainz MA, Louie SG, Petasi